Wealthcare Advisory Partners’s Celanese CE Stock Holding History

Wealthcare Advisory Partners’s Portfolio CE Stock Details CE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,278	Closed	-$220K	–	828
2024 Q1	$220K	Buy	+1,278	New	+$195K	0.01%	749
2021 Q2	–	Sell	-290	Closed	-$43K	–	757
2021 Q1	$43K	Buy	+290	New	+$39.8K	﹤0.01%	921
2020 Q2	–	Sell	-85	Closed	-$6K	–	469
2020 Q1	$6K	Hold	85	–	–	﹤0.01%	1040
2019 Q4	$10K	Hold	85	–	–	﹤0.01%	932
2019 Q3	$10K	Hold	85	–	–	﹤0.01%	916
2019 Q2	$9K	Hold	85	–	–	﹤0.01%	927
2019 Q1	$8K	Hold	85	–	–	﹤0.01%	858
2018 Q4	$8K	Hold	85	–	–	﹤0.01%	830
2018 Q3	$10K	Hold	85	–	–	﹤0.01%	836
2018 Q2	$9K	Hold	85	–	–	﹤0.01%	855
2018 Q1	$9K	Hold	85	–	–	﹤0.01%	743
2017 Q4	$9K	Hold	85	–	–	﹤0.01%	690
2017 Q3	$9K	Buy	+85	New	+$8.35K	﹤0.01%	559

Other funds holding CE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealthcare Advisory Partners's CE Position: Q2 2024 in Review

Wealthcare Advisory Partners sold out of Celanese (CE) in Q2 2024, closing a stake of 1,278 shares — an estimated $220K sold.

Wealthcare Advisory Partners first reported a position in CE in Q3 2017 and held it in 13 quarters. The position peaked at $220K in Q1 2024. 658 funds tracked by Wall St. Rank hold CE as of Q2 2024.

Wealthcare Advisory Partners reported no remaining Celanese position as of Q2 2024 after selling out during the quarter.
Wealthcare Advisory Partners sold 1,278 Celanese shares in Q2 2024, an estimated $220K.
Wealthcare Advisory Partners first reported a position in Celanese in Q3 2017 and held it in 13 quarters.
Wealthcare Advisory Partners's Celanese position peaked at $220K in Q1 2024.
658 funds tracked by Wall St. Rank held Celanese as of Q2 2024.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2024, filed 12 Aug 2024.